- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
Isotretinoin's discovery and development series
Dr. Jim Leyden, an active participant in isotretinoin's drug development process, discusses many of the important initial clinical observations and those that others have made over the years.
Dermatology Times editorial advisor, Dr. Elaine Siegfried talks with Jim Leyden, M.D., emeritus professor of dermatology at the University of Pennsylvania about the art and science of isotretinoin therapy. Dr. Leyden, an active participant in the drug development process, discusses many of the important initial clinical observations and those that others have made over the years.
READ: Full Interview
Dermatology Times editorial advisor, Dr. Elaine Siegfried discusses isotretinoin dosing and side effects with Jim Leyden, M.D., emeritus professor of dermatology at the University of Pennsylvania. Listen in and learn more.
READ: Full interview
Dermatology Times editorial advisor, Dr. Elaine Siegfried and Jim Leyden, M.D., emeritus professor of dermatology at the University of Pennsylvania discuss distinguishing sinus tracts or keratinous cysts from nodular areas of inflammation and techniques for treating via intralesional injection.
READ: Full interview
Dermatology Times editorial advisor, Dr. Elaine Siegfried and Jim Leyden, M.D., emeritus professor of dermatology at the University of Pennsylvania discuss whether a waiting period is necessary before treating acne scars and the questionable existence of pityrosporum folliculitis.
READ: Full interview
